ADMA BIOLOGICS INC's ticker is ADMA and the CUSIP is 000899104. A total of 74 filers reported holding ADMA BIOLOGICS INC in Q3 2019. The put-call ratio across all filers is 3.79 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $184,000 | -79.0% | 115,100 | -76.9% | 0.12% | -84.0% |
| Q1 2021 | $876,000 | -49.1% | 497,842 | -43.6% | 0.72% | -9.9% |
| Q4 2020 | $1,722,000 | +34.5% | 883,214 | +65.0% | 0.80% | +30.7% |
| Q3 2020 | $1,280,000 | -66.4% | 535,324 | -58.8% | 0.61% | -62.7% |
| Q2 2020 | $3,807,000 | +6.4% | 1,299,300 | +4.6% | 1.63% | -2.3% |
| Q1 2020 | $3,579,000 | +46.7% | 1,242,700 | +126.6% | 1.67% | +23.7% |
| Q3 2019 | $2,440,000 | +239.4% | 548,409 | +195.3% | 1.35% | +272.7% |
| Q2 2019 | $719,000 | – | 185,721 | – | 0.36% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Velan Capital Investment Management LP | 4,000,000 | $15,520,000 | 13.71% |
| Stonepine Capital Management, LLC | 6,940,000 | $26,927,200 | 11.33% |
| Caligan Partners LP | 2,676,093 | $10,383,241 | 8.64% |
| Altium Capital Management LP | 2,870,000 | $11,135,600 | 5.66% |
| AWM Investment Company, Inc. | 6,015,000 | $23,338,200 | 3.36% |
| EAM Investors, LLC | 1,749,598 | $6,788,440 | 1.40% |
| Perceptive Advisors | 11,900,255 | $46,172,989 | 1.30% |
| EAM Global Investors LLC | 836,323 | $3,244,933 | 0.84% |
| Potomac Capital Management, Inc. | 120,000 | $466 | 0.54% |
| OBERWEIS ASSET MANAGEMENT INC/ | 536,900 | $2,083,172 | 0.44% |